A prospective, open label clinical trial to evaluate the efficacy and safety of Tubby nutririch lotion for the treatment of dry skin with or without Atopic tendency in infants and children.

Sante Mernaud Pharmaceuticals Pvt Ltd0 个研究点目标入组 15 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patient has clinically infected atopic dermatitis at baseline.
•Patient with known hypersensitivity in general, to study drug or any excipients of the product
•Any dermatological condition other than atopic dermatitis that in the Investigators opinion may interfere with the evaluation of the patients atopic dermatitis
•Patients using non-sedating histamines least 7 days prior to the first dosing day or throughout the study.
•Severe Atopic Dermatitis
•History of other skin disorders, that could interfere with the evaluations
•Use of any topical treatment known or suspected to have an effect on atopic dermatitis within one week prior to the screen visit (except for calcineurin inhibitors, for which the washout is 2 weeks)
•Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
•Use of any other investigational agent in the last 30 days

发起方

Sante Mernaud Pharmaceuticals Pvt Ltd